On January 5, 2006 BD announced it is voluntarily initiating a notification to users of its blood glucose monitors in the United States, Canada and Germany. The products affected by the notification are: BD Logic®, BD Latitude™, Paradigm Link®, and The Link™. Patient safety and the efficacy of our products are BD’s top priorities. BD is informing its registered users, all customers, including distributors, retailers and healthcare professionals of this issue. Special instructions are being inserted into each new meter and test strip package. BD is working with the US Food and Drug Administration and Health Canada on this notification. BD has not received any reports of adverse health events in relation to this notification and BD will not be recalling any product.
For more information please click the link below to read the letter being sent to users of monitors in the US.